Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PDE4A Antikörper

Dieser Kaninchen Polyklonal Antikörper erkennt spezifisch PDE4A in WB, IHC, IF, ELISA, IP, ICC und CM. Er zeigt eine Reaktivität gegenüber Human, Maus, Ratte und Elch und wurde in 37+ Publikationen erwähnt.
Produktnummer ABIN2750880

Kurzübersicht für PDE4A Antikörper (ABIN2750880)

Target

Alle PDE4A Antikörper anzeigen
PDE4A (phosphodiesterase 4A, CAMP-Specific (PDE4A))

Reaktivität

  • 53
  • 34
  • 26
  • 7
  • 4
  • 4
  • 4
  • 3
  • 2
Human, Maus, Ratte, Elch

Wirt

  • 46
  • 7
Kaninchen

Klonalität

  • 48
  • 5
Polyklonal

Konjugat

  • 20
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser PDE4A Antikörper ist unkonjugiert

Applikation

  • 45
  • 16
  • 14
  • 13
  • 12
  • 6
  • 6
  • 6
  • 5
  • 4
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA, Immunoprecipitation (IP), Immunocytochemistry (ICC), Confocal Microscopy (CM)
  • Aufreinigung

    Affinity Purified

    Immunogen

    Synthetic cyclic peptide common to all PDE4A proteins.

    Isotyp

    IgG
  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.65-1.00 μg/μL
  • Avila, Barker, Zhang, McClain, Barve, Gobejishvili: "Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis." in: The Journal of pathology, Vol. 240, Issue 1, pp. 96-107, (2017) (PubMed).

    Massimi, Cardarelli, Galli, Giardi, Ragusa, Panera, Cinque, Cifone, Biagioni, Giorgi: "Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival." in: Journal of cellular biochemistry, Vol. 118, Issue 6, pp. 1401-1411, (2016) (PubMed).

    Petersen, Kristensen, Jeppesen, Grøndahl, Wissing, Macklon, Andersen: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).

    Kedia, Ückert, Oelke, Sonnenberg, Sohn, Kuczyk, Hedlund: "Expression and distribution of phosphodiesterase isoenzymes in the human male urethra." in: Urology, Vol. 85, Issue 4, pp. 964.e1-6, (2015) (PubMed).

    Yougbaré, Boire, Roy, Lugnier, Rouseau: "NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production." in: Canadian journal of physiology and pharmacology, Vol. 91, Issue 5, pp. 353-61, (2014) (PubMed).

    Guo, Lin, Zhao, Zhang, Wei, Wang, Wang: "Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice." in: Neuroscience, Vol. 263, pp. 1-14, (2014) (PubMed).

    Zhai, Chang, Wei, Liu, Leblais, Fischmeister, Ji: "Phosphodiesterase types 3 and 4 regulate the phasic contraction of neonatal rat bladder smooth myocytes via distinct mechanisms." in: Cellular signalling, Vol. 26, Issue 5, pp. 1001-10, (2014) (PubMed).

    Vang, Housley, Dong, Basole, Ben-Sasson, Kream, Epstein, Clark, Brocke: "Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac." in: The Biochemical journal, Vol. 456, Issue 3, pp. 463-73, (2013) (PubMed).

    Ückert, Waldkirch, Sonnenberg, Sandner, Kuczyk, Hedlund: "Expression and distribution of phosphodiesterase isoenzymes in the human seminal vesicles." in: The journal of sexual medicine, Vol. 8, Issue 11, pp. 3058-65, (2012) (PubMed).

    Waldkirch, Ückert, Sigl, Satzger, Geismar, Langnäse, Richter, Sohn, Kuczyk, Hedlund: "Expression of cyclic AMP-dependent protein kinase isoforms in human cavernous arteries: functional significance and relation to phosphodiesterase type 4." in: The journal of sexual medicine, Vol. 7, Issue 6, pp. 2104-2111, (2011) (PubMed).

    Abusnina, Alhosin, Keravis, Muller, Fuhrmann, Bronner, Lugnier: "Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis." in: Cellular signalling, Vol. 23, Issue 1, pp. 152-60, (2011) (PubMed).

    Yougbare, Morin, Senouvo, Sirois, Albadine, Lugnier, Rousseau: "NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues." in: American journal of physiology. Lung cellular and molecular physiology, Vol. 301, Issue 4, pp. L441-50, (2011) (PubMed).

    Vedin, Eriksson, Berghard: "Organization of the chemosensory neuroepithelium of the vomeronasal organ of the Scandinavian moose Alces alces." in: Brain research, Vol. 1306, pp. 53-61, (2010) (PubMed).

    Fatemi, Folsom, Reutiman, Braun, Lavergne: "Levels of phosphodiesterase 4A and 4B are altered by chronic treatment with psychotropic medications in rat frontal cortex." in: Synapse (New York, N.Y.), Vol. 64, Issue 7, pp. 550-5, (2010) (PubMed).

    Waldkirch, Uckert, Sigl, Langnaese, Richter, Stief, Kuczyk, Hedlund: "Expression of cAMP-dependent protein kinase isoforms in the human prostate: functional significance and relation to PDE4." in: Urology, Vol. 76, Issue 2, pp. 515.e8-14, (2010) (PubMed).

    Fatemi, Reutiman, Folsom, Lee: "Phosphodiesterase-4A expression is reduced in cerebella of patients with bipolar disorder." in: Psychiatric genetics, Vol. 18, Issue 6, pp. 282-8, (2009) (PubMed).

    Hörnberg, Gussing, Berghard, Bohm: "Retinoic acid selectively inhibits death of basal vomeronasal neurons during late stage of neural circuit formation." in: Journal of neurochemistry, Vol. 110, Issue 4, pp. 1263-75, (2009) (PubMed).

    Liu, Fraser, Koos: "Grueneberg ganglion olfactory subsystem employs a cGMP signaling pathway." in: The Journal of comparative neurology, Vol. 516, Issue 1, pp. 36-48, (2009) (PubMed).

    Zhang, Huang, Masood, Stolinski, Li, Zhang, Dlaboga, Jin, Conti, ODonnell: "Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B)." in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 33, Issue 7, pp. 1611-23, (2008) (PubMed).

    Braun, Reutiman, Lee, Folsom, Fatemi: "Expression of phosphodiesterase 4 is altered in the brains of subjects with autism." in: Neuroreport, Vol. 18, Issue 17, pp. 1841-4, (2008) (PubMed).

  • Target

    PDE4A (phosphodiesterase 4A, CAMP-Specific (PDE4A))

    Andere Bezeichnung

    PDE4A

    UniProt

    P27815

    Pathways

    cAMP Metabolic Process
Sie sind hier:
Chat with us!